Keryx Biopharmaceuticals, Inc.
(NASDAQ : KERX)

( )
KERX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading KERX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.31%165.221.3%$782.35m
GILDGilead Sciences, Inc.
-0.06%67.061.0%$564.12m
INCYIncyte Corporation
0.02%139.514.3%$556.22m
CELGCelgene Corporation
0.00%124.431.1%$495.09m
BIIBBiogen Inc.
-0.44%272.901.3%$436.77m
REGNRegeneron Pharmaceuticals, Inc.
0.14%383.102.1%$349.89m
KITEKite Pharma, Inc.
0.00%78.6117.5%$217.46m
ALXNAlexion Pharmaceuticals, Inc.
0.00%118.531.6%$201.95m
TSROTESARO, Inc.
0.00%154.9015.6%$193.40m
ILMNIllumina, Inc.
-0.47%170.003.4%$168.21m
VRTXVertex Pharmaceuticals Incorporated
20.16%107.752.0%$161.09m
ESPREsperion Therapeutics, Inc.
1.96%36.3617.7%$152.95m
CLVSClovis Oncology, Inc.
0.00%67.0617.2%$140.22m
AUPHAurinia Pharmaceuticals Inc.
0.84%7.228.0%$131.52m
EXELExelixis, Inc.
0.00%21.285.7%$104.55m

Company Profile

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.